Epoetin Beta Therapeutics Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025
- Transparency Market Research
Erythropoietin is a hormone released from the kidneys. Erythropoietin protein is responsible for the development of red blood cells (RBCs) in the body. Increase in the number of RBCs raises the level of hemoglobin in the blood, which is the substance responsible for transport of oxygen to every part of the body. Epoetin beta is one of the three erythropoiesis-stimulating agents available in the epoetin beta therapeutics market. It is used for the treatment of anemia in patients with severe kidney disease. Epoetin beta is given in combination with methoxy polyethylene glycol. One of the most common complications of chronic kidney disease is anemia. Its rate of prevalence with CKD is twice than the prevalence rate in the general population. Also, the rate of prevalence of anemia increased rapidly from stage 1 (8.4%) to stage 5 (53.4%) of CKD.
The epoetin beta therapeutics market is expected to expand rapidly during the forecast period, owing to factors such as increase in the prevalence of chronic kidney disease, increased returns on investment (RoI) as a result of patent expiry of drugs, focus of government and non-profit organizations on creating awareness about anemia, research and development grants, and tax credits offered.
Based on drug type, the epoetin beta therapeutics market has been segmented into biologics and biosimilars. The biologics segment dominated the epoetin beta therapeutics market in 2016. However, epoetin beta therapeutics segment is anticipated to expand at a slow pace during the forecast period, as patents for biologic drugs have recently expired and biosimilar drugs for epoetin beta are being made available in the epoetin beta therapeutics market in a few countries. The biosimilars segment is expected to register a rapid growth rate during the forecast period, owing to the reduced cost of biosimilar drugs as compared to biologics. Based on distribution channel, the epoetin beta therapeutics market has been segmented into hospital pharmacy, retail pharmacy, and online pharmacy. The hospital pharmacy segment dominated the epoetin beta therapeutics market in 2016 and is anticipated to remain dominant during the forecast period as well. The online pharmacy segment is anticipated to expand at a significantly high CAGR during the forecast period, owing to factors such as extending reach of online pharmacies to customers, rising availability of Internet facilities globally, and other services such as cost containment offered by online pharmacies.
Geographically, the global epoetin beta therapeutics market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global epoetin beta therapeutics market in 2016 and is anticipated to remain dominant during the forecast period also. Growth of the epoetin beta therapeutics market in the region can be attributed to the increasing number of approvals of erythropoietin drugs and incentives offered for research on chronic kidney diseases by governments in the region.
Europe is expected to follow the North America region during the forecast period. Growth of the epoetin beta therapeutics market in the Europe region can be attributed to the rising prevalence of chronic diseases in the region. The epoetin beta therapeutics market in Asia Pacific is expected to expand at the highest CAGR during the forecast period. High rate of incidence of hematological diseases in countries such as India, China, Bangladesh, and Pakistan is likely to drive the epoetin therapeutics market in Asia Pacific between 2017 and 2025.
Major players operating in the global epoetin therapeutics market include Roche, Haemato Pharm, F. Hoffmann-La Roche Ltd., and Bosnia & Herzegovina.
The report offers a comprehensive evaluation of the epoetin beta therapeutics market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the epoetin beta therapeutics market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and epoetin beta therapeutics market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent epoetin beta therapeutics market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Pharmaceutical
PharmaceuticalChinese Markets for Mental Illness Drugs
PharmaceuticalChinese Markets for Anti-Dermatomycosis Skin Drugs
PharmaceuticalChinese Markets for Incretion Drugs
PharmaceuticalChinese Markets for Hypertension Drugs
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017